Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FAAH | O00519 | 5/20 | 0.45 |
| ▸ | CES1 | P23141 | 2/20 | 0.45 |
| ▸ | NQO1 | P15559 | 1/20 | 0.44 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.43 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.43 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.43 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.43 |
| ▸ | SOAT2 | O75908 | 1/20 | 0.43 |
| ▸ | SOAT1 | P35610 | 1/20 | 0.43 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3948789 | 0.86 | EPHX2 (0.38) | FAAHCES1SOAT2SOAT1EPHX2 | |
| SCHEMBL5351493 | 0.78 | FAAH (0.45) | FAAHSOAT2SOAT1EPHX2 | |
| SCHEMBL3952916 | 0.78 | ALDH1A1 (0.44) | CYP1A2CYP3A4CYP2C9 | |
| SCHEMBL29215813 | 0.78 | FAAH (0.43) | FAAHSOAT2SOAT1EPHX2 | |
| SCHEMBL669128 | 0.78 | NQO1 (0.43) | NQO1 | |
| SCHEMBL8665344 | 0.77 | F7 (0.53) | FAAHSOAT2SOAT1EPHX2 | |
| SCHEMBL8665350 | 0.77 | F7 (0.53) | FAAHSOAT2SOAT1EPHX2 | |
| SCHEMBL2025362 | 0.76 | EPHX2 (0.47) | FAAHCYP3A4EPHX2 | |
| SCHEMBL3958792 | 0.76 | NDUFS8 (0.45) | FAAHCES1EPHX2 | |
| SCHEMBL30850816 | 0.76 | SOAT2 (0.51) | FAAHCYP1A2CYP3A4CYP2C9CYP2C19 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1924671-A4 | FLUORESCENT MARKER COMPRISING DOUBLE BOND ESTER GROUP AND METHOD FOR MARKING AND DETECTING THE SAME | SIM HYUN-HO (KR) | 2009-07-15 | — | — | EP | disclosed |
| US-20090104711-A1 | FLUORESCENT MARKER COMPRISING DOUBLE BOND ESTER GROUP AND METHOD FOR MARKING AND DETECTING THE SAME | SIM HYUN-HO | 2009-04-23 | — | — | US | disclosed |
| EP-1924671-A1 | FLUORESCENT MARKER COMPRISING DOUBLE BOND ESTER GROUP AND METHOD FOR MARKING AND DETECTING THE SAME | Sim, Hyun-Ho (KR) | 2008-05-28 | — | — | EP | disclosed |
| WO-2007037586-A1 | FLUORESCENT MARKER COMPRISING DOUBLE BOND ESTER GROUP AND METHOD FOR MARKING AND DETECTING THE SAME | SIM HYUN-HO (KR) | 2007-04-05 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090104711-A1 | FLUORESCENT MARKER COMPRISING DOUBLE BOND ESTER GROUP AND METHOD FOR MARKING AND DETECTING THE SAME | ELOVL1, FASN, ELOVL5 | FAAH 190/4885CES1 197/4885NQO1 323/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.